Showing results (2501-2510 of 2,948) with videos related to

Sort By:
Pageof 295
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 18, 2020
A novel sensitive assay for detection of a biomarker of pericyte injury in cerebrospinal fluidMelanie D Sweeney, Abhay P Sagare, Maricarmen Pachicano, et al.
Journal of the International Neuropsychological Society : JINS|September 5, 2022
Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's diseaseJessica Nicosia, Andrew J Aschenbrenner, David A Balota, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 16, 2018
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging InitiativeDallas P Veitch, Michael W Weiner, Paul S Aisen, et al.
Infection and Immunity|September 12, 2018
YraP Contributes to Cell Envelope Integrity and Virulence of Salmonella enterica Serovar TyphimuriumFaye C Morris, Timothy J Wells, Jack A Bryant, et al.
Journal of Computer-Aided Molecular Design|April 29, 2006
Discovering new classes of Brugia malayi asparaginyl-tRNA synthetase inhibitors and relating specificity to conformational changeSai Chetan K Sukuru, Thibaut Crepin, Youli Milev, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 5, 2013
Improving dementia care: the role of screening and detection of cognitive impairmentSoo Borson, Lori Frank, Peter J Bayley, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2017
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trialsMichael W Weiner, Dallas P Veitch, Paul S Aisen, et al.
Human Molecular Genetics|February 10, 2025
Whole-genome sequencing reveals the impact of lipid pathway and APOE genotype on brain amyloidosisMaulikkumar Patel, Cyril Pottier, Kang-Hsien Fan, et al.
ACS Chemical Biology|January 31, 2017
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye DiseaseJennifer Batson, Hamish D Toop, Clara Redondo, et al.
Pageof 295